Digital Content 
NEWS #PharmaBuzz
17 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/17/3063328/0/en/Avadel-and-nference-Announce-Publication-of-Real-World-Data-on-Sodium-Oxybate-Treatment-Patterns-in-the-Journal-of-Clinical-Neuroscience.html
09 Apr 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/jazz-pharma-pay-145-million-settle-narcolepsy-drug-antitrust-case-2025-04-08/
17 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/17/2964979/0/en/Avadel-Pharmaceuticals-Announces-FDA-Approval-of-LUMRYZ-sodium-oxybate-Extended-Release-Oral-Suspension-CIII-for-the-Treatment-of-Cataplexy-or-Excessive-Daytime-Sleepiness-in-Patie.html
25 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/25/2952920/0/en/Avadel-Pharmaceuticals-Announces-Publication-of-Data-Highlighting-Efficacy-of-LUMRYZ-sodium-oxybate-Extended-Release-Oral-Suspension-in-Improving-Narcolepsy-Symptoms-Regardless-of-.html
03 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/03/2939609/0/en/Avadel-Pharmaceuticals-Announces-Publication-of-RESTORE-Data-Highlighting-Challenges-with-Twice-Nightly-Oxybates-and-Strong-Patient-Preference-for-Once-Nightly-LUMRYZ-Dosing-sodium.html
20 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/20/2932758/0/en/Avadel-Pharmaceuticals-Announces-Publication-in-Clinical-Therapeutics-of-Data-Highlighting-Weight-Loss-in-People-with-Narcolepsy-Treated-with-LUMRYZ-sodium-oxybate-Extended-Release.html
Share 